Dang, T.
Faje, A. T.
Meenaghan, E.
Bredella, M. A.
Bouxsein, M. L.
Klibanski, A.
Fazeli, P. K. http://orcid.org/0000-0003-1731-2927
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL 1TR002541)
National Center for Research Resources (UL1 RR025758, 1S10RR023405)
National Institutes of Health (R24 DK084970, P30 DK040561, K24DK109940, R01 HD099139)
Article History
Received: 16 May 2022
Accepted: 5 August 2022
First Online: 23 August 2022
Declarations
:
: PKF is a consultant for Regeneron and Strongbridge Biopharma. Tran Dang, Alexander Faje, Erinne Meenaghan, Miriam Bredella, Mary Bouxsein and Anne Klibanski declare they have no conflict of interest.